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By M. G. NELSON, M.D., M.R.C.P., M.R.C.P.(I.), D.T.M. & H.
Clinical Pathological Laboratory, Royal Victoria Hospital, Bclfast
ANAEMIA in pregnancy is *a problem of considerable interest both to the family
doctor and to the obstetrician. It is a problem with two main practical aspects.
One is that ana-mic women are a poor obstetric risk and tolerate badly the loss of
blood during normal delivery. The other is that inadequate treatment of anremia
during pregnancy or the puerperium may result in a woman in a lowered state of
health being returned, not only to the burden of child rearing but also to her
ordinary domestic duties. Briscoe stated in 1952 that "the post-partum an;emic
patient who must resume caring for her family needs fast restoration of her
strength." Whether we are engaged in general or hospital practice, we should
face up to both aspects of this problem and do our best to solve them. I have been
invited to contribute this short paper in order to assist those engaged in the
management of an;emias of pregnancy and to present the current views on this
subject.
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FIG. 1
The drain on maternal iron reserves during normal pregnancy.
It has been said that "the ana~mias primarily due to pregnancy are essentially
nutritional anaemias caused by the drain on the maternal reserves created by the
demands of the foetus." Such a demand results in a depletion of the maternal
reserves of iron or folic acid, thus producing respectively either iron-deficiency or
megaloblastic anwemia of pregnancy.
IRON-DEFICIENCY ANAMIA.
The most frequent type of anamia of pregnancy is iron-deficiency an;emia. This
is characterised by a microcytic hypochromic picture in the peripheral blood, a low
colour index, a low M.C.H.C. (i.e., less than 30 per cent.) and a normoblastic
19hyperplasia in the bone marrow. The main causes of iron deficiency anoemia in
pregnancy are the foetal demands for iron; the loss of blood during placental
delivery and post-partum haemorrhage, together with further transfer of iron from
the mother during lactation (Fig. 1).
The total amount of iron lost to the mother during pregnancy, parturition and
lactation is of the order of 900 mgms. (Davidson and Fullerton, 1938.) Further
factors which may contribute to iron deficiency in the mother are a poor appetite,
low acid content in the stomach and possibly bleeding from haemorrhoids. The
effect of these losses of iron during pregnancy may be enhanced because of an
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FIG. 2
The distribution and deficiency of body iron in various states.
already low maternal iron reserve. The constant menstrual losses of iron which
are incompletely replaced due to dietary deficiency leads to depletion of iron in the
tissues and the body stores, although antemia may not always be present (Fig. 2).
The importance of "masked iron deficiency" (i.e., depleted iron reserves with
normal haemoglobin and erythrocyte levels) has been stressed by continental
workers. The presence of "masked"' iron deficiency may be suspected from the
presence of vague symptoms of lassitude and weakness dating from a previous
pregnancy or incomplete abortion. The technique at present used to detect a
"masked" deficiency is to determine the serum iron levels after a test dose of oral
iron (Jasinski, 1952). In the normal individual with well-filled iron stores little or
no iron is absorbed from the gut and the serum iron levels do not rise significantly.
In "masked" iron deficiency the biological need for iron to fill the depleted stores
results in iron absorption, and high serum iron levels are obtained after oral
ingestion of a test dose of a readily absorbed iron preparation. A similar-curve is
also found in iron-deficiency anemia (Fig. 3). Using this test, Jasinski and Dierner
(1952) considered that some 40 per cent. of pregnant or recently delivered women
showed evidence of "masked" iron deficiency.
20The diagnosis of iron-deficiency anemia in pregnancy can be readily made on
examination of the peripheral blood. The presence of a disproportionate fall of the
hawmoglobin level compared with the erythrocyte count resulting in a low colour
index is suggestive. The determination of the M.C.H.C. will provide more reliable
proof, and if the M.C.H.C. is 30 per cent. or less then iron-deficiency anaemia is
present. Once a diagnosis of either iron-deficiency anaemia or "masked" iron
deficiency has been made, the best treatment is the oral administration of a
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FIG. 3
The serum iron level after an oral test dose of absorbable iron salt.
satisfactory oral iron preparation. By satisfactory is meant an iron preparation
which not only produces little gastro-intestinal upset but also one which is both
readily absorbed and readily utilised for hemoglobin synthesis. It is already well
known that ferrous salts of iron are therapeutically more effective than ferric salts,
but the utilisation co-efficient of the various ferrous salts is probably less well
known. A histogram has been constructed to show graphically the utilisation of
iron from the common iron salts employed in the manufacture of various pharma-
ceutical preparations of iron for oral use (Fig. 4). The utilisation co-efficient factor
used for comparative purposes in this diagram is the percentage of iron expressed
as metal which is utilised for the synthesis of hwmoglobin during an observed
period. The figure used for each preparation was the average utilisation percentage
as reported in the literature. In the case of ferrous succinate the figure of 41 per
cent. was obtained from a therapeutic trial of twenty-five patients carried out else-
where and not, as yet, reported in the literature. Clinical trials with ferrous
succinate carried out in this centre on a small number of patients have resulted in
a most satisfactory clinical and haematological response, although the utilisation
co-efficient obtained has not been as high as 41 per cent. However, the trial is not
yet sufficiently extensive to allow of any definite conclusions beyond the fact that
ferrous succinate is at least as therapeutically effective as ferrous gluconate and is
21very well tolerated. The advantages of using ferrous instead of ferric salts is
readily apparent from the histogram; also, the more satisfactory utilisation of iron
from ferrous gluconate and succinate than from ferrous sulphate.
In the case of oral iron preparations, the question of patient tolerance or absence
from side effects must be carefully considered. Preparations containing ferrous
sulphate are particularly prone to produce intestinal disturbances, even when given
in gradually increasing dosage and with meals. It was largely because of this that
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FIG. 4
The utilisation co-efficient of iron for various iron salts used therapeutically.
Benstead and Theobald (1952) stated that "ferrous sulphate is not a suitable
preparation for the routine administration of iron in ante-natal clinics." On the
other hand, ferrous gluconate and ferrous succinate are well tolerated, readily
absorbed and rapidly utilised.
In the treatment of iron-deficiency anremia it is essential not only to raise the
haemoglobin as rapidly as possible to normal but also to restore the body reserves
of iron. This twofold objective can only be achieved if treatment is adequate and
maintained for much longer than has been the practice in the past. The dose and
duration of treatment will depend on the degree of iron deficiency but, once the
anaemia has been corrected, treatment should be continued for a further six weeks
in order to fill the depleted body stores of iron. A similar period of -six weeks'
treatment is necessary for "masked" iron deficiency without anawmia.
The use of intravenous iron therapy has come greatly into vogue in obstetric
practice where this form of treatment is used much more widely than in general
practice. While it may be necessary in some cases of severe iron-deficiency anamia
detected shortly before delivery to attempt to improve the peripheral blood rapidly,
in general, the indications for the use of intravenous iron therapy are limited. It
should never be resorted to unless the presence of iron-deficiency anaemia has been
22proven or unless adequate oral iron therapy has already been tried. It should never
be given in a total dose greater than that calculated to be necessary or in a single
dose greater than 5 mls., i.e., 100 mgms. The practice of massive dose intravenous
iron therapy is strongly to be condemned and the danger has already been stressed
(Ramsey, 1950). Only if patients are unable to tolerate oral iron therapy, or are
proved to be completely resistant to it, should intravenous therapy be used.
One of the toxic effects of intravenous iron therapy is a syncopal-like attack
followed by rigors, pyrexia, headache, pain in the back and limbs. This may prove
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FIG. 5
The response in a case of iron deficiency anamia to oral ferrous succinate.
dangerous not only to the mother but also to the feetus in utero. This toxic effect is
probably caused by an over-saturation of the normal iron transport mechanism in
the plasma, and is much more likely to occur if intravenous iron treatment is given
to patients who are not primarily iron deficient. Normally, iron is transported in
the blood in the globulin fraction of the plasma protein which is usually one-third
saturated with iron. However, the degree of iron saturation of the globulin is much
less in iron-deficiency anaemia. -Consequently, the unsaturated globulin can, as it
were, mop up more of the iron injected directly into the circulation than the already
more saturated globulin of normal blood. Over-saturation of the iron transport
mechanism will result in iron saccharate circulating freely throughout the body
with the risk of cell damage and venospasm.
In some cases of iron-deficiency anaemia resistant to oral iron therapy parenteral
administration of iron by the intravenous route may not be possible either because
of absence of suitable veins or because of repeated reactions to the intravenous
injections. For such patients a preparation suitable for intramuscular injection is
now available. This is a dextran-iron solution which is isotonic with tissue fluid
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Iand contains 5 per cent. of iron as metal. It has been estimated that each 2 ml.
of this preparation injected intramuscularly will cause a rise of 0.34 g. of
hwemoglobin per 100 ml. of blood. The technique of injection requires care if local
pain or skin staining are to be avoided. The injection should be made into the
gluteal muscles through an Z-shaped track. For these and other reasons intra-
muscular iron should not be given as a routine treatment to all cases of iron-
deficiency antemia, the majority of which will respond satisfactorily to an adequate
oral iron preparation.
Intensive iron treatment should, in most instances, result in a rapid response and
early recovery, but it may on occasions be necessary to increase the oxygen-
carrying capacity of blood more rapidly. Transfusions of sedimented or packed
red cells are most satisfactory for this purpose.
MEGALOBLASTIC ANAEMIA OF PREGNANCY.
This condition is produced by a temporary deficiency of folic acid. It is likely to
occur when the maternal diet is low in protein and folic acid (Spies, 1949) and
therefore inadequate to meet both maternal needs and the growing foetal demands.
The term pernicious anaemia of pregnancy is frequently used for this syndrome,
but it has little resemblance to Addisonian pernicious anwmia either in the ;etiology,
peripheral blood picture or therapeutic requirements, although in both the bone
marrow is megaloblastic. For these reasons the non-specific title of "megaloblastic
anaemia of pregnancy"' is preferable and is now widely used.
The condition is probably much more common than is generally realised. A
gradual awakening of clinical awareness to the possibility of this condition has
resulted in the diagnosis of many more cases. Of the last four cases of anaemia
in pregnancy which I was asked to see in the Royal Maternity Hospital, three were
megaloblastic anaemias of pregnancy.
Common in young multipara, the onset is usually in the last trimester or even
delayed until the puerperium and may be precipitated by some infection. Gastro-
intestinal symptoms are frequent with anorexia, nausea, and vomiting. The tongue
is often sore and on examination raw, red, and beefy. The facies, in my experience,
resemble pre-eclamptic toxeemia with which it is often confused. The face is pallid
but not icteric, and the contours are obliterated. There may even be peripheral
oedema and proteinuria. The presence of a histamine-fast achlorhydria is merely
coincidental and not essential for the diagnosis.
Examination of the peripheral blood rarely shows the presence of a macrocytic
anaemia-the blood picture being far more often normocytic in type. The cells are
well filled with haemoglobin and the M.C.H.C. within the normal range. It may be
said that, in the absence of recent htemorrhage, any severe anaemia of pregnancy or
the puerperium which is not of the iron-deficiency type should be suspected as
megaloblastic anteriia of pregnancy until proven otherwise.
Because the findings in the peripheral blood are seldom of themselves diagnostic,
it can be inferred that the diagnosis can only be made on examination of an
aspiration sample of bone marrow. This has now become such a routine procedure
in most clinical pathological laboratories that it presents no difficulties. The presence
24in the bone marrow of the typical megaloblasts with basophilic cytoplasm and a
nucleus with a scroll-like chromatin pattern of primitive appearance is too well
known to need repetition.
It has already been established that megaloblastic anaemia of pregnancy does not
respond satisfactorily to parenteral therapy with vitamin B12 or purified liver
extract. It does respond, however, to treatment with parenteral crude liver extract
or folic acid. The treatment of choice is folic acid, preferably given by injection for
rapid and maximal effect, in doses of the order of 20-40 mgm./day. As the deficiency
is temporary, the treatment need not be maintained, once the anaemia is cured, the
body stores replaced and the patient restored to a normal diet.
In some cases, the deficiency of folic acid may be associated with a deficiency of
iron and, consequently, treatment with folic acid alone may be followed by a
suboptimal response. The addition of oral iron supplement will result in rapid
restoration of the peripheral blood to normal (Fig. 6).
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FIG. 6
The response in a case of megaloblastic anaemia of pregnancy
to oral folic acid later combined with oral iron.
In the past a tendency to spontaneous remission of megaloblastic anaemia of
pregnancy after delivery had been noted. This was produced by a reduction in the
maternal loss of folic acid to the foetus after delivery and a return to a more normal
diet, presumably rich in folic acid. A partial or complete remission may also be
produced by transfusion with whole blood. It was these facts which led obste-
tricians to believe that megaloblastic anaemia of pregnancy would always recover
spontaneously after delivery and that this recovery would be hastened by blood
transfusion. Under such circumstances, however, restoration to normal health was
slow and often incomplete, whereas recovery can be hastened and made complete
by folic acid- treatment.
25lhe effect of wlhole blood transfusion on megaloblastic anmemia of pregnancy is
probably identical with its effect on megaloblastic an:emia of infancy which is also
a condition produced by a temporary deficiency of folic acid. Occasional cases of
this syndrome have been cured by whole blood transfusion alone (Zuelzer and
Ogden, 1946; Nelson and Creery, 1955). It has been shown by transfusion with
plasma and plasma-free erythrocytes that the curative effect resides in the normal
donor plasma which is considered to provide enough anti-megaloblastic substances
to induce a remission.
There is an unexplained tendency for megaloblastic anaemia to relapse in
subsequent pregnancies or even in the absence of pregnancy if an intercurrent
infection supervenes to increase the body needs for folic acid. Thus, it would
appear that these patients live on a very precarious folic acid balance. For this
reason, all patients who have suffered from megaloblastic anmemia of pregnancy
should in all subsequent pregnancies have prophylactic oral folic acid therapy
particularly in the later months.
In megaloblastic an;aemia of pregnancy there is a possibility of the development
of a folic acid deficiency in the child. This may lead to the subsequent development
of megaloblastic amemia in the infant (Zetterstrom and Franzen, 1954). It would
seem logical, therefore, to supplement with folic acid the diet of all infants born of
mothers suffering from untreated megaloblastic anaemia of pregnancy.
SUMMARY.
The anaemias of pregnancy caused by increased fcetal demands on the maternal
reserve are presented.
The causes of iron-deficiency ana.mia are discussed and oral treatment with a
well-tolerated, readily absorbed and rapidly utilised preparation of a ferrous salt
stressed. The indications and contraindications to intravenous iron therapy are
briefly mentioned.
It is probable that megaloblastic anaemia of pregnancy is more common than
realised, largely due to the fact that the diagnosis can only be made on examination
of the bone marrow. Treatment with folic acid is curative.
In megaloblastic an;zemia of pregnancy the need for prophylactic treatment of the
mother in a subsequent pregnancy and of the infant born of a woman suffering from
untreated megaloblastic anaemia of pregnancy is mentioned.
I wish to thank my senior laboratory technician, Mr. A. Lamont, F.I.M.L.T., for the
graphs and histograms which he produced to illustrate this paper.
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